FIELD: medicine.
SUBSTANCE: method of treating chronic kidney disease, as well as reducing the albumin/creatinine ratio and stabilizing the estimated glomerular filtration rate in a subject, having chronic kidney disease (CKD) due to congenital anomalies of kidney and urinary tract (CAKUT), involves percutaneous injection into a renal cortex of at least one kidney of a subject of an effective amount of a composition containing a population of selective renal cells.
EFFECT: group of inventions provides improved renal function.
36 cl, 15 tbl, 2 ex, 9 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING CELL VESICLES AND USE THEREOF | 2019 |
|
RU2824136C2 |
| IMMUNOLOGICALLY PRIVILEGED BIOACTIVE KIDNEY CELLS FOR TREATMENT OF KIDNEY DISEASE | 2018 |
|
RU2816753C2 |
| ORGANOIDS CONTAINING ISOLATED RENAL CELLS, AND THEIR USE | 2014 |
|
RU2722361C2 |
| ALPORT SYNDROME TREATMENT OPTIONS | 2018 |
|
RU2791694C2 |
| RENAL CELL POPULATIONS AND THEIR USE | 2013 |
|
RU2805243C2 |
| KIDNEY CELL POPULATIONS AND USE THEREOF | 2013 |
|
RU2702721C2 |
| METHODS OF TREATING POLYCYSTIC KIDNEY DISEASE | 2016 |
|
RU2742300C2 |
| SLIT-ROBO SIGNALLING FOR DIAGNOSIS AND TREATMENT OF KIDNEY DISEASE | 2013 |
|
RU2674153C2 |
| METHOD FOR THE DIAGNOSIS AND/OR PROGNOSIS OF ACUTE RENAL DAMAGE | 2012 |
|
RU2657422C2 |
| METHODS AND SYSTEMS FOR MONITORING HEALTH AND PATHOLOGY OF ORGANS | 2020 |
|
RU2818052C2 |
